These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress. Li C; Liu Q; Xie L Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891 [TBL] [Abstract][Full Text] [Related]
44. Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice. Dumeus S; Shibu MA; Lin WT; Wang MF; Lai CH; Shen CY; Lin YM; Viswanadha VP; Kuo WW; Huang CY Cell Physiol Biochem; 2018; 48(5):1942-1952. PubMed ID: 30092591 [TBL] [Abstract][Full Text] [Related]
45. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice. Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684 [TBL] [Abstract][Full Text] [Related]
46. Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo. Liu W; Shang J; Deng Y; Han X; Chen Y; Wang S; Yang R; Dong F; Shang H J Ethnopharmacol; 2022 Sep; 295():115382. PubMed ID: 35577161 [TBL] [Abstract][Full Text] [Related]
47. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Wang ZQ; Zhang XH; Yu Y; Tipton RC; Raskin I; Ribnicky D; Johnson W; Cefalu WT Metabolism; 2013 Sep; 62(9):1239-49. PubMed ID: 23702383 [TBL] [Abstract][Full Text] [Related]
48. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism. Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG Front Immunol; 2020; 11():148. PubMed ID: 32158445 [TBL] [Abstract][Full Text] [Related]
49. Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice. Kung ML; Cheng SM; Wang YH; Cheng KP; Li YL; Hsiao YT; Tan BC; Chen YW Commun Biol; 2024 May; 7(1):594. PubMed ID: 38760406 [TBL] [Abstract][Full Text] [Related]
50. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065 [TBL] [Abstract][Full Text] [Related]
51. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6. Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567 [TBL] [Abstract][Full Text] [Related]
52. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672 [TBL] [Abstract][Full Text] [Related]
53. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice. Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948 [TBL] [Abstract][Full Text] [Related]
54. AMPK-α2 is involved in exercise training-induced adaptations in insulin-stimulated metabolism in skeletal muscle following high-fat diet. Abbott MJ; Turcotte LP J Appl Physiol (1985); 2014 Oct; 117(8):869-79. PubMed ID: 25103967 [TBL] [Abstract][Full Text] [Related]
56. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. Martínez R; Kapravelou G; Donaire A; Lopez-Chaves C; Arrebola F; Galisteo M; Cantarero S; Aranda P; Porres JM; López-Jurado M Food Funct; 2018 Feb; 9(2):830-850. PubMed ID: 29364302 [TBL] [Abstract][Full Text] [Related]
57. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice. Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955 [TBL] [Abstract][Full Text] [Related]
58. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488 [TBL] [Abstract][Full Text] [Related]
59. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695 [TBL] [Abstract][Full Text] [Related]
60. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]